Αρχειοθήκη ιστολογίου

Δευτέρα 15 Ιανουαρίου 2018

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus

Type 2 diabetes mellitus is associated with cognitive dysfunction and an increased risk of dementia. Linagliptin is a glucose-lowering agent of the dipeptidyl peptidase-IV (DPP-IV) inhibitor class that is of p...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2EI65tN

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου